Freeline Therapeutics Holdings plc (NASDAQ: FRLN) is now covered by analysts at Redburn Partners. They set a "neutral" rating on the stock.
Freeline Therapeutics Holdings plc - ADSs (FRLN)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
FRLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FRLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FRLN alerts
High impacting Freeline Therapeutics Holdings plc - ADSs news events
Weekly update
A roundup of the hottest topics
FRLN
News
- Acquisition of Freeline by Syncona Becomes Effective [Yahoo! Finance]Yahoo! Finance
- Acquisition of Freeline by Syncona Becomes EffectiveGlobeNewswire
- Freeline Shareholders Approve Acquisition by Syncona [Yahoo! Finance]Yahoo! Finance
- Freeline Shareholders Approve Acquisition by SynconaGlobeNewswire
- FREELINE THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Freeline Therapeutics Holdings plc - FRLNPR Newswire
FRLN
Sec Filings
- 2/20/24 - Form SC
- 2/20/24 - Form 25-NSE
- 2/20/24 - Form 6-K
- FRLN's page on the SEC website